Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly
Stroke is a major cause of both death and disability. However, there are no pharmacological treatments used in most countries other than recombinant tissue plasminogen activator, a thrombolytic, and this is only used in about 4% of patients presenting after an acute ischaemic stroke. One novel throm...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Revisão |
| 言語: | 英語 |
| 出版事項: |
2007
|
| オンライン･アクセス: | https://doi.org/10.1038/sj.bjp.0707594 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|